Literature DB >> 15469041

Regulation mechanisms of vanilloid receptors.

Makoto Tominaga1, Mitsuko Numazaki, Tohko Iida, Tomoko Moriyama, Kazuya Togashi, Tomohiro Higashi, Namie Murayama, Tomoko Tominaga.   

Abstract

The capsaicin receptor TRPV1 (also known as the vanilloid receptor VR1) is a non-selective cation channel and is activated not only by capsaicin but also by noxious heat or protons. Tissue damage associated with infection, inflammation or ischaemia, produces an array of chemical mediators that activate or sensitize nociceptor terminals. An important component of this pro-algeic response is ATP. In cells expressing TRPV1, ATP increased the currents evoked by capsaicin or protons through activation of P2Y metabotropic receptors in a PKC-dependent manner. In the presence of ATP, the temperature threshold for TRPV1 activation was reduced from 42 degrees C to 35 degrees C, such that normal body temperature could activate TRPV1. Functional interaction between P2Y receptors and TRPV1 was confirmed in a behavioural analysis using TRPV1-deficient mice. Direct phosphorylation of TRPV1 by PKC was confirmed biochemically and the two serine residues involved were identified. Extracellular Ca2+ -dependent desensitization of TRPV1 is thought to be one mechanism underlying the paradoxical effectiveness of capsaicin as an analgesic therapy. The Ca2+ -binding protein calmodulin binds to the C-terminus of TRPV1. We found that disruption of the calmodulin binding segment prevented TRPV1 desensitization even in the presence of extracellular Ca2+.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15469041

Source DB:  PubMed          Journal:  Novartis Found Symp        ISSN: 1528-2511


  9 in total

Review 1.  Structure-function analysis of TRPV channels.

Authors:  Barbara A Niemeyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-04       Impact factor: 3.000

2.  The emerging role of TRP channels in mechanisms of temperature and pain sensation.

Authors:  Gina M Story
Journal:  Curr Neuropharmacol       Date:  2006-07       Impact factor: 7.363

3.  Inflammatory pain: the cellular basis of heat hyperalgesia.

Authors:  Jiehong Huang; Xuming Zhang; Peter A McNaughton
Journal:  Curr Neuropharmacol       Date:  2006-07       Impact factor: 7.363

4.  β-Arrestin-2 desensitizes the transient receptor potential vanilloid 1 (TRPV1) channel.

Authors:  Elaine D Por; Sonya M Bierbower; Kelly A Berg; Ruben Gomez; Armen N Akopian; William C Wetsel; Nathaniel A Jeske
Journal:  J Biol Chem       Date:  2012-09-05       Impact factor: 5.157

5.  Changes in synaptic effectiveness of myelinated joint afferents during capsaicin-induced inflammation of the footpad in the anesthetized cat.

Authors:  P Rudomin; E Hernández
Journal:  Exp Brain Res       Date:  2008-02-05       Impact factor: 1.972

6.  TRESK gene recombinant adenovirus vector inhibits capsaicin-mediated substance P release from cultured rat dorsal root ganglion neurons.

Authors:  Jun Zhou; Shang-Long Yao; Cheng-Xiang Yang; Ji-Ying Zhong; Han-Bing Wang; Yan Zhang
Journal:  Mol Med Rep       Date:  2012-02-03       Impact factor: 2.952

7.  Inhibition of TRPA1 channel activity in sensory neurons by the glial cell line-derived neurotrophic factor family member, artemin.

Authors:  Naoki Yoshida; Kimiko Kobayashi; Lina Yu; Shenglan Wang; Rengaowa Na; Satoshi Yamamoto; Koichi Noguchi; Yi Dai
Journal:  Mol Pain       Date:  2011-05-27       Impact factor: 3.395

8.  Activation of mu opioid receptors sensitizes transient receptor potential vanilloid type 1 (TRPV1) via β-arrestin-2-mediated cross-talk.

Authors:  Matthew P Rowan; Sonya M Bierbower; Michael A Eskander; Kalina Szteyn; Elaine D Por; Ruben Gomez; Nicholas Veldhuis; Nigel W Bunnett; Nathaniel A Jeske
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

Review 9.  3-Iodothyronamine, a Novel Endogenous Modulator of Transient Receptor Potential Melastatin 8?

Authors:  Noushafarin Khajavi; Stefan Mergler; Heike Biebermann
Journal:  Front Endocrinol (Lausanne)       Date:  2017-08-16       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.